Are There Clinical Trials or New Treatments for CADASIL?

As of 2026, no treatment has been proven to stop or reverse CADASIL (a disease-modifying treatment) ^[1]. The medical community’s focus is on managing symptoms, reducing vascular risk factors like high blood pressure, and providing individualized care for strokes or migraines ^[2][3]. While there is no established cure, scientists are exploring several experimental avenues in laboratories that may eventually lead to new therapies ^[4][5].

What the Research Says About Specific Therapies

It is common to look for information on specific drugs or supplements to find hope. Here is where the current evidence stands on some commonly discussed therapies.

L-arginine and Blood Flow Therapies

CADASIL involves impaired blood flow in the brain’s small blood vessels. This has led to questions about whether vasodilators—substances that widen blood vessels—might help. L-arginine is an amino acid that helps produce nitric oxide, which relaxes blood vessels. However, current clinical evidence does not establish L-arginine or other nitric-oxide therapies as an effective treatment for CADASIL ^[6].

Important safety note: Do not start taking L-arginine or other over-the-counter supplements without talking to your doctor. These products can affect your blood pressure and interact with your prescribed medications ^[7]. Just because a supplement is available without a prescription does not mean it is proven safe for someone with a complex vascular condition.

There is a planned clinical study in Japan, known as LOMCAD, looking at lomerizine (a different medication, not L-arginine) to see if it might help prevent ischemic events (problems caused by reduced blood flow, such as strokes or transient ischemic attacks) in CADASIL patients ^[6]. As of current literature, this study has not reported safety or effectiveness results ^[6].

Donepezil and Cognitive Medications

Because CADASIL can cause cognitive decline and vascular dementia (memory and thinking problems caused by reduced blood flow to the brain), patients often ask about medications used for Alzheimer’s disease. These include drugs like donepezil (Aricept), rivastigmine, or memantine.

The available clinical evidence does not establish donepezil or similar drugs as disease-modifying treatments specifically for CADASIL ^[8]. This lack of proven efficacy does not mean these medications are universally unsafe, but their overall benefits for CADASIL are not consistently proven ^[8]. Major medical guidelines do not recommend them as established therapies for this condition ^[1][2]. If you are experiencing cognitive changes, your doctor can discuss the potential benefits and adverse effects of trying these medications on a case-by-case basis.

Experimental Gene Therapies and ASOs

CADASIL is caused by mutations in a single gene called NOTCH3. Genetic therapies offer a logical target, but research in this area is currently preclinical. This means it is being tested in cells and animal models in a laboratory, not in human patients ^[5][4]. Preclinical success does not guarantee that a treatment will be safe or effective in humans, nor does it provide a clear timeline for when a treatment might become available.

Scientists are investigating strategies to fix or work around the NOTCH3 mutations:

• Antisense oligonucleotides (ASOs) and RNA therapies: These are experimental molecules designed to interfere with the genetic instructions that create the harmful protein ^[9][10]. Researchers are exploring whether altering these proteins could help, but they must be careful because simply suppressing the NOTCH3 protein could disrupt its normal, necessary functions in the body ^[11][12].
• Gene Editing: Researchers have successfully used precise gene-editing tools (like adenine base editing) to correct NOTCH3 mutations in patient-derived cells and lab-grown blood vessel models ^[4].

Translating these laboratory results into human treatments faces major barriers. Researchers must figure out how to safely deliver these therapies into the specific cells of the human brain’s blood vessels, account for the many different variations of NOTCH3 mutations, and prevent off-target effects (unintended genetic changes or effects elsewhere in the body) ^[13][14].

Participating in Clinical Trials and Research

Because there is no definitive treatment, clinical trials and research are critical ^[2]. If you are considering participating, it is important to understand the different types of studies and what they involve.

Types of Studies

• Observational Studies: Researchers track your symptoms, cognitive function, and MRI changes over time to better understand how the disease progresses ^[15][16]. You do not receive an experimental treatment. This helps establish a baseline against which future drugs can be tested.
• Interventional Trials: These studies test new drugs or therapies. You may occasionally find trials testing symptom management ^[17].

What to Consider Before Joining a Trial

Participating in an interventional trial is not a guaranteed route to a personal treatment or cure. Consider the following realities:

• Placebos and Randomization: You may be randomly assigned to receive a placebo (an inactive substance) rather than the experimental drug.
• Risks and Unknowns: Experimental therapies can have unknown adverse effects.
• Logistics: Trials often require extra doctor visits, travel, out-of-pocket costs, and intensive testing (like blood draws or MRIs).
• Data Privacy: Genetic studies will collect your DNA and health data. It is highly recommended to speak with a genetic counselor and the study coordinator to discuss data sharing, privacy, and how the results might impact you and your family.

To find current trials, you or your doctor can search databases like ClinicalTrials.gov. Keep in mind that a registry listing does not mean a study is currently recruiting, appropriate for you, or endorsed by your care team. Always discuss potential trials with your neurologist to ensure they align with your health goals and current standard of care.